Raess Matthieu A, Friant Sylvie, Cowling Belinda S, Laporte Jocelyn
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 Rue Laurent Fries, BP10142, 67404 Illkirch, France; INSERM U964, 67404 Illkirch, France; CNRS, UMR7104, 67404 Illkirch, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, 67404 Illkirch, France; Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, 21 Rue Descartes, 67084 Strasbourg, France.
Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, 21 Rue Descartes, 67084 Strasbourg, France.
Adv Biol Regul. 2017 Jan;63:49-58. doi: 10.1016/j.jbior.2016.09.001. Epub 2016 Sep 15.
Myotubularins define a large family of proteins conserved through evolution. Several members are mutated in different neuromuscular diseases including centronuclear myopathies and Charcot-Marie-Tooth (CMT) neuropathies, or are linked to a predisposition to obesity and cancer. While some members have phosphatase activity against the 3-phosphate of phosphoinositides, regulating the phosphorylation status of PtdIns3P and PtdIns(3,5)P implicated in membrane trafficking and autophagy, and producing PtdIns5P, others lack key residues in the catalytic site and are classified as dead-phosphatases. However, these dead phosphatases regulate phosphoinositide-dependent cellular pathways by binding to catalytically active myotubularins. Here we review previous studies on the molecular regulation and physiological roles of myotubularins. We also used the recent myotubularins three-dimensional structures to underline key residues that are mutated in neuromuscular diseases and required for enzymatic activity. In addition, through database mining and analysis, expression profile and specific isoforms of the different myotubularins are described in depth, as well as a revisited protein interaction network. Comparison of the interactome and expression data for each myotubularin highlights specific protein complexes and tissues where myotubularins should have a key regulatory role.
肌管蛋白定义了一个在进化过程中保守的蛋白质大家族。该家族的几个成员在不同的神经肌肉疾病中发生突变,包括中央核性肌病和夏科-马里-图斯(CMT)神经病,或者与肥胖和癌症的易感性有关。虽然一些成员具有针对磷酸肌醇3-磷酸的磷酸酶活性,可调节参与膜运输和自噬的磷脂酰肌醇3-磷酸(PtdIns3P)和磷脂酰肌醇(3,5)二磷酸(PtdIns(3,5)P)的磷酸化状态,并产生磷脂酰肌醇5-磷酸(PtdIns5P),但其他成员在催化位点缺乏关键残基,被归类为失活磷酸酶。然而,这些失活磷酸酶通过与具有催化活性的肌管蛋白结合来调节磷酸肌醇依赖性细胞途径。在此,我们回顾了以往关于肌管蛋白分子调控和生理作用的研究。我们还利用最近的肌管蛋白三维结构来强调在神经肌肉疾病中发生突变且是酶活性所必需的关键残基。此外,通过数据库挖掘和分析,深入描述了不同肌管蛋白的表达谱和特定异构体,以及重新构建的蛋白质相互作用网络。对每个肌管蛋白的相互作用组和表达数据进行比较,突出了肌管蛋白应具有关键调控作用的特定蛋白质复合物和组织。